Background: The adequacy of the artificial Nutritional Support (NS) in the critical care patient has implications in morbidity and prognosis. Clinical practice guidelines (CPG) are an important tool for healthcare professionals in their daily practice and a method of consultation for the correct treatment of patients. Also, the evidence remains low and there are important controversies regarding the NS in the critical care patient. Hypothesis: The NS generates great controversy in the professionals involved in the care of critical care patients due to the contradictory results in literature. Despite this, the CPG should serve to standardize the treatment of patients and provide a better adherence to current knowledge in this setting. The importance of NS is underestimated and there is a need to perform proper evaluation of the impact of nutrition. Objectives: To evaluate and analyze NS practices in critically ill patients in different ICUs and assess the adherence to CPGs. To evaluate the relationship of nutrition and outcomes in the ICU. Methodology: Prospective multicenter observational study. Collection of variables from different participating ICUs and the characteristics of the NS of the different admitted patients. Monitoring of nutritional practices and complications. Evaluation of outcomes (e.g. mortality, ICU complications, etc.) with NS. Expected results: Better understanding of the NS and its impact on morbidity and mortality; development of strategies to reduce low adherence to CPGs, improving the quality of care associated with this field in critical care patients; obtain clinical information that will serve as a basis for conducting intervention studies.
Methods (additional information): The NS (Nutritional Support) in the ICUs will be administered according to the usual practice of the medical and nursing staff and to the protocols established in each unit. The rate of initiation, the dose of macronutrients and the increase in contributions will be made according to the criteria of each participating ICU and the responsible physician (including the use of prokinetics or parenteral nutrition). All the complications described associated with the artificial Nutritional support and others related to the critical patient will be evaluated daily by the research team and reflected in the electronic data collection form (eCRF). The eCRF has been carried out through the REDCAP ™ platform and designed by the Department of Information Technology of Lleida of the Universitari Arnau de Vilanova Hospital, under the supervision of Dr. Lluís Servià, principal investigator of the present project. The responsible of the computer centre is Joan Escobar-Ortiz. The data will be stored in a server of the center and will be coded to comply with the confidentiality of the same and for a correct anonymization of patients based on Regulatory Laws. The study has the approval of each ethics committee of each participating centre. Statistical analyses will be performed by the department of statistics of University of Lleida under close supervision of Javier Trujillano-Cabello and the principal investigators of the present study.
Study Type
OBSERVATIONAL
Enrollment
642
Evaluation of Enteral Nutrition or Parenteral Nutrition or both administered to the patients needing artificial Nutritional Support
Hospital Sant Joan d' Alacant
Sant Joan d'Alacant, Alicante, Spain
H. Manacor
Manacor, Balearic Islands, Spain
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
H. General de Granollers
Granollers, Barcelona, Spain
Hospital Universitari de Bellvitge (Cardiology Unit)
L'Hospitalet de Llobregat, Barcelona, Spain
Kilocalories delivered by enteral and/or parenteral route and Energy balance
Kilocalories delivered by nutritional support - (minus) nutritional support target in Kilocalories
Time frame: Daily to a maximum of 14 days after Intensive Care Unit Admission
gram of proteins delivered by enteral and/or parenteral route
Proteins delivered by nutritional support - (minus) nutritional support target in gram of proteins
Time frame: Daily to a maximum of 14 days after Intensive Care Unit Admission
Rate of complications related with nutritional support (Enteral and/or Parenteral route)
Main artificial nutritional support serious complications (i.e. constipation, higher residual gastric volume, vomiting, diarrhea associated with enteral nutrition, meseteric ischemia) requiring a therapeutical intervention or modification of the nutritional support - safety related variable
Time frame: Daily to a maximum of 14 days after Intensive Care Unit Admission
Rate of 28-day mortality associated with the characteristics of nutritional support (e.g., gram of proteins, etc.)
Influence of nutritional support or any nutrition-related variable on mortality during ICU admission
Time frame: Daily to a maximum of 28 days after Intensive Care Unit Admission
Time from Intensive Care Unit admission to the start of enteral nutrition
Time frame in hours from Intensive Care Unit admission to the start of enteral nutrition
Time frame: Up to 120 hours after Intensive Care Unit Admission
Dose of vasoactive drugs
Dose of vasoactive drugs (highest daily), in μg/kg/min
Time frame: Daily to a maximum of 14 days after Intensive Care Unit Admission
Glycaemic control
Daily measurement of maximum and minimum glucose
Time frame: Daily to a maximum of 14 days after Intensive Care Unit Admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital de Mataró
Mataró, Barcelona, Spain
Hospital Mutua Terrasa.
Terrassa, Barcelona, Spain
Hospital General Universitario de Castellón
Castellon, Castellón, Spain
Hospital Universitario de Puerto Real
Puerto Real, Cádiz, Spain
...and 33 more locations